Back to top

LB Pharmaceuticals accelerates Phase 3 schizophrenia trial timeline

LB Pharmaceuticals, Inc. ( ($LBRX) ) just unveiled an announcement. On July 22, 2026, LB Pharmaceuticals announced that faster-than-expected enroll...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: